PENANG, Malaysia, June 6, 2025 /PRNewswire/ — Quantum Metal Recovery Inc. (QMRI), the largest shareholder of Besra Gold Inc. (Besra), has issued a formal response to Besra’s 22 May 2025 ASX announcement titled “Market Update: Clarification of Quantum Presentation” and its accompanying Management Information Circular. QMRI disagrees entirely with the contents of both documents, describing them as partisan, inflammatory, and, in some instances, potentially defamatory.
On 15 May 2025, QMRI initiated legal proceedings in the Superior Court of Justice (Ontario), seeking relief related to its ongoing effort to replace Besra’s incumbent board. The Notice of Application is publicly filed and available here. QMRI intends to pursue this effort either through the scheduled shareholders’ meeting or by court order.
As part of its continued commitment to shareholder interests, QMRI has nominated three independent directors with extensive mining industry experience:
Contrary to the Management Circular, QMRI’s nominees to the board of Besra are at arm’s length to QMRI and Dato Lim and were independently selected by an executive recruitment agency for their industry experience and specialised knowledge in international mining projects, including gold projects.
Despite Besra’s recent interim board appointments, QMRI expresses concern that meaningful progress on the Bau Gold Project has stalled. It believes its proposed nominees will bring transparency, expertise, and effective oversight to realign the company with its contractual obligations and shareholder expectations.
To view the full statement and supporting details, including the legal filing, please click here.
Media Contact: Corporate Communications Department
Quantum Metals Recovery Inc.
qmri.press@gmail.com
View original content:https://www.prnewswire.co.uk/news-releases/quantum-metal-recovery-inc-responds-to-besra-golds-asx-announcement-initiates-legal-proceedings-in-ontario-302475239.html
Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions…
– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…
This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which…
May 29, 2026 21:18 ET | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…
MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…